凍結乾燥生弱毒麻疹・風疹混合ワクチン（シュワルツFF-8株／TO-336株）2回目のワクチン接種後の被接種者における特定薬剤使用状況調査

基本情報

NCT ID: NCT02158364
ステータス: 完了
試験のフェーズ: -
試験タイプ: 観察
目標被験者数: 3,331
治験依頼者名: Takeda

概要

The purpose of this survey is to assess the safety of freeze-dried live attenuated measles and rubella combined vaccine (Schwarz FF-8 strain/TO-336 strain) (freeze-dried live attenuated measles and rubella combined vaccine "Takeda") in terms of the occurrence of unknown/known adverse drug reactions and factors that may influence the safety of vaccinees after the second vaccination.

対象疾患

Measles/Rubella

介入

Freeze-dried live attenuated measles and rubella combined vaccine (Schwarz FF-8 strain/TO-336 strain)(DRUG)

依頼者（Sponsor）

武田薬品工業株式会社(INDUSTRY)